Back
Artiva Biotherapeutics Stock Price Chart
Sponsored
ARTV
Sponsored
The AI Energy Miracle
Details Here.
Sell
31
ARTV
Artiva Biotherapeutics
Last Price:
$11.13
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Artiva Biotherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.68 | Buy |
20-day SMA: | 11.58 | Sell |
50-day SMA: | 11.71 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 10.8 | Buy |
20-day EMA: | 11.25 | Sell |
50-day EMA: | 11.5 | Sell |
200-day EMA: | 7.8 | Buy |
Artiva Biotherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 47.9 | Sell |
Chaikin Money Flow: | 230412 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.5 - 12.3) | Sell |
Bollinger Bands (100): | (10.35 - 13.41) | Sell |
Artiva Biotherapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Artiva Biotherapeutics Stock
Is Artiva Biotherapeutics Stock a Buy?
-
Artiva Biotherapeutics share price is 11.11 while ARTV 8-day simple moving average is 10.68, which is a Buy signal.
-
The stock price of ARTV is 11.11 while Artiva Biotherapeutics 20-day SMA is 11.58, which makes it a Sell.
-
Artiva Biotherapeutics 50-day simple moving average is 11.71 while ARTV share price is 11.11, making it a Sell technically.
-
ARTV stock price is 11.11 and Artiva Biotherapeutics 200-day simple moving average is 0.00, creating a Buy signal.
ARTV Technical Analysis vs Fundamental Analysis
Sell
31
Artiva Biotherapeutics (ARTV)
is a Sell
Is Artiva Biotherapeutics a Buy or a Sell?
-
Artiva Biotherapeutics stock is rated a SellThe current Artiva Biotherapeutics [ARTV] share price is $11.11. The Score for ARTV is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Artiva Biotherapeutics Stock Info
Market Cap:
195.4M
Price in USD:
11.11
Share Volume:
352.8K
Artiva Biotherapeutics 52-Week Range
52-Week High:
17.31
52-Week Low:
9.68
Sell
31
Artiva Biotherapeutics (ARTV)
is a Sell
Artiva Biotherapeutics Share Price Forecast
-
What is the Artiva Biotherapeutics stock price today?The Artiva Biotherapeutics stock price is 11.11 USD today.
-
Will ARTV stock go up or go down?Artiva Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Artiva Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Artiva Biotherapeutics is overvalued.
Is Artiva Biotherapeutics Stock a Buy?
-
Artiva Biotherapeutics share price is 11.11 while ARTV 8-day exponential moving average is 10.80, which is a Buy signal.
-
The stock price of ARTV is 11.11 while Artiva Biotherapeutics 20-day EMA is 11.25, which makes it a Sell.
-
Artiva Biotherapeutics 50-day exponential moving average is 11.50 while ARTV share price is 11.11, making it a Sell technically.
-
ARTV stock price is 11.11 and Artiva Biotherapeutics 200-day simple moving average is 7.80, creating a Buy signal.
Fundamental Analysis of Artiva Biotherapeutics
Is Artiva Biotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $2.47 per share.
Technical Analysis of Artiva Biotherapeutics
Should I short Artiva Biotherapeutics stock?
-
ARTV Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting Artiva Biotherapeutics is a Sell
-
Artiva Biotherapeutics Relative Strength Index (RSI) is 47.9, which suggest Artiva Biotherapeutics is oversold
-
The Bollinger Bands (25) for Artiva Biotherapeutics is (10.5 - 12.3), which suggest Artiva Biotherapeutics is a Sell
-
The Bollinger Bands (100) for Artiva Biotherapeutics is (10.35 - 13.41), which suggest Artiva Biotherapeutics is a Sell
* Artiva Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.